Human Genome Editing in the Clinic: New Challenges in Regulatory Benefit-Risk Assessment

被引：27

作者：

Abou-El-Enein, Mohamed ^{[1
]}

Cathomen, Toni ^{[2
,3
]}

Ivics, Zoltan ^{[4
]}

June, Carl H. ^{[5
]}

Renner, Matthias ^{[4
]}

Schneider, Christian K. ^{[6
]}

Bauer, Gerhard ^{[7
]}

机构：

[1] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany

[2] Univ Freiburg, Med Ctr, Inst Transfus Med & Gene Therapy, Freiburg, Germany

[3] Univ Freiburg, Fac Med, Freiburg, Germany

[4] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany

[5] Univ Penn, Ctr Cellular Therapies, Perelman Sch Med, Philadelphia, PA 19104 USA

[6] Med & Healthcare Prod Regulatory Agcy, NIBSC, S Mimms, Herts, England

[7] Univ Calif Davis, IRC, Sacramento, CA 95817 USA

来源：

CELL STEM CELL | 2017年 / 21卷 / 04期

关键词：

TECHNOLOGIES; NUCLEASES;

D O I：

10.1016/j.stem.2017.09.007

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

As genome editing rapidly progresses toward the realization of its clinical promise, assessing the suitability of current tools and processes used for its benefit-risk assessment is critical. Although current regulations may initially provide an adequate regulatory framework, improvements are recommended to overcome several existing technology-based safety and efficacy issues.

引用

页码：427 / 430

页数：4

共 10 条

[1] Overcoming Challenges Facing Advanced Therapies in the EU Market [J].

Abou-El-Enein, Mohamed ;

Elsanhoury, Ahmed ;

Reinke, Petra .

CELL STEM CELL, 2016, 19 (03) :293-297

[2] Genome Engineering with Targetable Nucleases [J].

Carroll, Dana .

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83, 2014, 83 :409-439

[3] Refining strategies to translate genome editing to the clinic [J].

Cornu, Tatjana I. ;

Mussolino, Claudio ;

Cathomen, Toni .

NATURE MEDICINE, 2017, 23 (04) :415-423

[4] Genome Editing Technologies: Defining a Path to Clinic [J].

Corrigan-Curay, Jacqueline ;

O'Reilly, Marina ;

Kohn, Donald B. ;

Cannon, Paula M. ;

Bao, Gang ;

Bushman, Frederic D. ;

Carroll, Dana ;

Cathomen, Toni ;

Joung, J. Keith ;

Roth, David ;

Sadelain, Michel ;

Scharenberg, Andrew M. ;

von Kalle, Christof ;

Zhang, Feng ;

Jambou, Robert ;

Rosenthal, Eugene ;

Hassani, Morad ;

Singh, Aparna ;

Porteus, Matthew H. .

MOLECULAR THERAPY, 2015, 23 (05) :796-806

[5] Gene therapy returns to centre stage [J].

Naldini, Luigi .

NATURE, 2015, 526 (7573) :351-360

[6] Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells [J].

Qasim, Waseem ;

Zhan, Hong ;

Samarasinghe, Sujith ;

Adams, Stuart ;

Amrolia, Persis ;

Stafford, Sian ;

Butler, Katie ;

Rivat, Christine ;

Wright, Gary ;

Somana, Kathy ;

Ghorashian, Sara ;

Pinner, Danielle ;

Ahsan, Gul ;

Gilmour, Kimberly ;

Lucchini, Giovanna ;

Inglott, Sarah ;

Mifsud, William ;

Chiesa, Robert ;

Peggs, Karl S. ;

Chan, Lucas ;

Farzaneh, Farzin ;

Thrasher, Adrian J. ;

Vora, Ajay ;

Pule, Martin ;

Veys, Paul .

SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (374)

[7] Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition [J].

Ren, Jiangtao ;

Liu, Xiaojun ;

Fang, Chongyun ;

Jiang, Shuguang ;

June, Carl H. ;

Zhao, Yangbing .

CLINICAL CANCER RESEARCH, 2017, 23 (09) :2255-2266

[8] Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV [J].

Tebas, Pablo ;

Stein, David ;

Tang, Winson W. ;

Frank, Ian ;

Wang, Shelley Q. ;

Lee, Gary ;

Spratt, S. Kaye ;

Surosky, Richard T. ;

Giedlin, Martin A. ;

Nichol, Geoff ;

Holmes, Michael C. ;

Gregory, Philip D. ;

Ando, Dale G. ;

Kalos, Michael ;

Collman, Ronald G. ;

Binder-Scholl, Gwendolyn ;

Plesa, Gabriela ;

Hwang, Wei-Ting ;

Levine, Bruce L. ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (10) :901-910

[9] Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases [J].

Tsai, Shengdar Q. ;

Joung, J. Keith .

NATURE REVIEWS GENETICS, 2016, 17 (05) :300-312

[10] Delivery technologies for genome editing [J].

Yin, Hao ;

Kauffman, Kevin J. ;

Anderson, Daniel G. .

NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (06) :387-399

← 1 →